Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy
Gespeichert in:
| Veröffentlicht in: | Pediatric blood & cancer 2011-07, Vol.56 (7), p.1149-1150 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1150 |
|---|---|
| container_issue | 7 |
| container_start_page | 1149 |
| container_title | Pediatric blood & cancer |
| container_volume | 56 |
| creator | Chen, Rong-Long Chuang, Shih-Sung Lu, Yi-Hsuan |
| description | |
| doi_str_mv | 10.1002/pbc.22894 |
| format | Article |
| fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_pbc_22894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_S8VTBJLQ_G</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2904-3d60e8cab46e4303bfe04d3f40cf99ee4e23260c7e8e2a99524fbe032b94e26a3</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0E4lFY8APIWxahju28lrQqBVRREAWWluNMiCFpIjsB-g98NC4p3bGyNXPmSvcgdOqTC58QOmxSdUFpnPAddOgHPPAC4ke72z9JDtCRtW8ODUkQ76MD6jMWhVF0iL4XBmRbwbLFdY4bU78asFbXS5x1Ri9fsYGsU63-gPWyKaQFnNcGNxIyLVujlZvrSpoVrtYT2-qlLPHIU1CWuFxVTVFXEnd2nZXVFjyZvXW2hQxP7ufja6wKqOq2ACOb1THay2Vp4WTzDtDT1WQxvvZm8-nN-HLmKZoQ7rEsJBArmfIQOCMszYHwjOWcqDxJADhQ5pqqCGKgMkkCyvMUCKNp4lahZAN03ucqU1trIBebDsInYm1UOKPi16hjz3q26VLXcEv-KXTAsAc-dQmr_5PE_Wj8F-n1F9p5-NpeSPMuwohFgXi5m4rH-Hkxup09iCn7AQuTkvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chen, Rong-Long ; Chuang, Shih-Sung ; Lu, Yi-Hsuan</creator><creatorcontrib>Chen, Rong-Long ; Chuang, Shih-Sung ; Lu, Yi-Hsuan</creatorcontrib><identifier>ISSN: 1545-5009</identifier><identifier>EISSN: 1545-5017</identifier><identifier>DOI: 10.1002/pbc.22894</identifier><identifier>PMID: 21337677</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cyclophosphamide - therapeutic use ; Dose-Response Relationship, Drug ; Doxorubicin - therapeutic use ; Etoposide - therapeutic use ; Female ; Humans ; Lymphoma, B-Cell - drug therapy ; Mediastinal Neoplasms - drug therapy ; Prednisone - therapeutic use ; Tomography, X-Ray Computed ; Treatment Outcome ; Vincristine - therapeutic use</subject><ispartof>Pediatric blood & cancer, 2011-07, Vol.56 (7), p.1149-1150</ispartof><rights>Copyright © 2011 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2904-3d60e8cab46e4303bfe04d3f40cf99ee4e23260c7e8e2a99524fbe032b94e26a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpbc.22894$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpbc.22894$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21337677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Rong-Long</creatorcontrib><creatorcontrib>Chuang, Shih-Sung</creatorcontrib><creatorcontrib>Lu, Yi-Hsuan</creatorcontrib><title>Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy</title><title>Pediatric blood & cancer</title><addtitle>Pediatr. Blood Cancer</addtitle><subject>Adolescent</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Doxorubicin - therapeutic use</subject><subject>Etoposide - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Mediastinal Neoplasms - drug therapy</subject><subject>Prednisone - therapeutic use</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Vincristine - therapeutic use</subject><issn>1545-5009</issn><issn>1545-5017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0E4lFY8APIWxahju28lrQqBVRREAWWluNMiCFpIjsB-g98NC4p3bGyNXPmSvcgdOqTC58QOmxSdUFpnPAddOgHPPAC4ke72z9JDtCRtW8ODUkQ76MD6jMWhVF0iL4XBmRbwbLFdY4bU78asFbXS5x1Ri9fsYGsU63-gPWyKaQFnNcGNxIyLVujlZvrSpoVrtYT2-qlLPHIU1CWuFxVTVFXEnd2nZXVFjyZvXW2hQxP7ufja6wKqOq2ACOb1THay2Vp4WTzDtDT1WQxvvZm8-nN-HLmKZoQ7rEsJBArmfIQOCMszYHwjOWcqDxJADhQ5pqqCGKgMkkCyvMUCKNp4lahZAN03ucqU1trIBebDsInYm1UOKPi16hjz3q26VLXcEv-KXTAsAc-dQmr_5PE_Wj8F-n1F9p5-NpeSPMuwohFgXi5m4rH-Hkxup09iCn7AQuTkvo</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Chen, Rong-Long</creator><creator>Chuang, Shih-Sung</creator><creator>Lu, Yi-Hsuan</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20110701</creationdate><title>Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy</title><author>Chen, Rong-Long ; Chuang, Shih-Sung ; Lu, Yi-Hsuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2904-3d60e8cab46e4303bfe04d3f40cf99ee4e23260c7e8e2a99524fbe032b94e26a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Doxorubicin - therapeutic use</topic><topic>Etoposide - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Mediastinal Neoplasms - drug therapy</topic><topic>Prednisone - therapeutic use</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Vincristine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Rong-Long</creatorcontrib><creatorcontrib>Chuang, Shih-Sung</creatorcontrib><creatorcontrib>Lu, Yi-Hsuan</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Pediatric blood & cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Rong-Long</au><au>Chuang, Shih-Sung</au><au>Lu, Yi-Hsuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy</atitle><jtitle>Pediatric blood & cancer</jtitle><addtitle>Pediatr. Blood Cancer</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>56</volume><issue>7</issue><spage>1149</spage><epage>1150</epage><pages>1149-1150</pages><issn>1545-5009</issn><eissn>1545-5017</eissn><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21337677</pmid><doi>10.1002/pbc.22894</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1545-5009 |
| ispartof | Pediatric blood & cancer, 2011-07, Vol.56 (7), p.1149-1150 |
| issn | 1545-5009 1545-5017 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_pbc_22894 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Adolescent Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cyclophosphamide - therapeutic use Dose-Response Relationship, Drug Doxorubicin - therapeutic use Etoposide - therapeutic use Female Humans Lymphoma, B-Cell - drug therapy Mediastinal Neoplasms - drug therapy Prednisone - therapeutic use Tomography, X-Ray Computed Treatment Outcome Vincristine - therapeutic use |
| title | Treatment of progression during reductive prophase for paediatric primary mediastinal B-cell lymphoma using dose-adjusted EPOCH chemotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T08%3A24%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20progression%20during%20reductive%20prophase%20for%20paediatric%20primary%20mediastinal%20B-cell%20lymphoma%20using%20dose-adjusted%20EPOCH%20chemotherapy&rft.jtitle=Pediatric%20blood%20&%20cancer&rft.au=Chen,%20Rong-Long&rft.date=2011-07-01&rft.volume=56&rft.issue=7&rft.spage=1149&rft.epage=1150&rft.pages=1149-1150&rft.issn=1545-5009&rft.eissn=1545-5017&rft_id=info:doi/10.1002/pbc.22894&rft_dat=%3Cistex_cross%3Eark_67375_WNG_S8VTBJLQ_G%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/21337677&rfr_iscdi=true |